Pacific Biosciences of California, Inc. (PACB) Stock Grade

About Pacific Biosciences of California, Inc.'s fundamentals

Pacific Biosciences of California is a medical device company with a market capitalization of $560.9 million that generated revenue growth of 3.9% year-over-year. However, the company is currently unprofitable, reporting a net margin of -341.5% and a net loss in its latest annual statement, indicating that expenses substantially exceed revenues. The company does not pay a dividend, and traditional profitability metrics like price-to-earnings ratio and return on equity are not applicable given the loss position.